? ? The goal of this program is to prepare M.D., M.D./Ph.D. or Ph.D. postdoctoral fellows for biomedical research careers in Transfusion Medicine. This recently (2001) formed Program in Transfusion Biology and Medicine has a broad scope of clinical and basic research activities all of which relate to hematopoietic cell therapy: Blood Banking (the collection, processing and storage of peripheral blood and bone marrow derived cells), Clinical Transfusion Medicine (transfusion/transplantation of mature and stem/progenitor blood cells; cellular immunotherapy), and Transfusion Biology (cellular and molecular biology of blood cells, immunity of blood cells, cellular engineering of stem and immune-competent blood cells). The major Harvard Medical School (HMS) affiliated institutions participating in the training program include Children's Hospital Boston (CHB), CBR Institute for Biomedical Research (CBRI), Dana-Farber Cancer Institute (DFCI), Brigham and Women's Hospital (BWH), and Beth Israel-Deaconess Medical Center (BIDMC). During the first funding period, we have developed a multi-disciplinary program utilizing the strong clinical and basic research environments at HMS. Dr. Leslie Silberstein will continue as the Program Director, and Dr. Denisa Wagner as the Co-Director. Our approach of including rather than excluding faculty is a fundamental strength of our program and fits well with the broad nature of Transfusion Medicine and our overall mission to facilitate cross-fertilization of clinical, basic and translational research talent. The outstanding pool of applicants and recruitment of faculty dedicated to the program has facilitated this goal. Our faculty, consisting of physicianscientists (M.D., M.D./Ph.D.) or PhD scientists, represent a broad range of disciplines, many of whom are not only connected through this postdoctoral training program but also through other Harvard wide, multiinstitutional programs, e.g. Harvard Stem Cell Institute, Center for Human Cell Therapy, Dana Farber-Harvard Cancer Center, NHLBI funded Clinical Trials Network in Transfusion Medicine/Hemostasis. During the past five years, this training program has supported 22 trainees (6 M.D., 6 M.D./Ph.D., 10 Ph.D.). Of these, seven have faculty positions, one is in residency training, and one has a position in biotechnology industry; eleven remain in training. The current Training Program is considered to be unique in the U.S. and is expected to continue to provide a rich training environment for academic transfusion medicine. (End of Abstract) ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL066987-08
Application #
7465338
Study Section
Special Emphasis Panel (ZHL1-CSR-J (F1))
Program Officer
Mondoro, Traci
Project Start
2001-09-01
Project End
2011-06-30
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
8
Fiscal Year
2008
Total Cost
$477,533
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02115
Witsch, Thilo; Martinod, Kimberly; Sorvillo, Nicoletta et al. (2018) Recombinant Human ADAMTS13 Treatment Improves Myocardial Remodeling and Functionality After Pressure Overload Injury in Mice. J Am Heart Assoc 7:
Kapp, Friedrich G; Perlin, Julie R; Hagedorn, Elliott J et al. (2018) Protection from UV light is an evolutionarily conserved feature of the haematopoietic niche. Nature 558:445-448
Kim, Ah Ram; Sankaran, Vijay G (2018) Thrombopoietin: tickling the HSC's fancy. EMBO Mol Med 10:10-12
Gavillet, Mathilde; Martinod, Kimberly; Renella, Raffaele et al. (2018) A key role for Rac and Pak signaling in neutrophil extracellular traps (NETs) formation defines a new potential therapeutic target. Am J Hematol 93:269-276
Zitomersky, Naamah L; Demers, Melanie; Martinod, Kimberly et al. (2017) ADAMTS13 Deficiency Worsens Colitis and Exogenous ADAMTS13 Administration Decreases Colitis Severity in Mice. TH Open 1:e11-e23
Blaser, Bradley W; Moore, Jessica L; Hagedorn, Elliott J et al. (2017) CXCR1 remodels the vascular niche to promote hematopoietic stem and progenitor cell engraftment. J Exp Med 214:1011-1027
Hudak, Jason E; Alvarez, David; Skelly, Ashwin et al. (2017) Illuminating vital surface molecules of symbionts in health and disease. Nat Microbiol 2:17099
Dotiwala, Farokh; Sen Santara, Sumit; Binker-Cosen, Andres Ariel et al. (2017) Granzyme B Disrupts Central Metabolism and Protein Synthesis in Bacteria to Promote an Immune Cell Death Program. Cell 171:1125-1137.e11
Theodore, Lindsay N; Hagedorn, Elliott J; Cortes, Mauricio et al. (2017) Distinct Roles for Matrix Metalloproteinases 2 and 9 in Embryonic Hematopoietic Stem Cell Emergence, Migration, and Niche Colonization. Stem Cell Reports 8:1226-1241
Martinod, Kimberly; Witsch, Thilo; Erpenbeck, Luise et al. (2017) Peptidylarginine deiminase 4 promotes age-related organ fibrosis. J Exp Med 214:439-458

Showing the most recent 10 out of 87 publications